Filter Results:
(176)
Show Results For
- All HBS Web
(176)
- People (1)
- News (51)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
Show Results For
- All HBS Web
(176)
- People (1)
- News (51)
- Research (84)
- Events (3)
- Multimedia (8)
- Faculty Publications (52)
- 01 Dec 2020
- News
Digital Health Care: Empowering Consumers
symptoms of diseases like diabetes or congestive heart failure. Before the implantable congestive heart failure monitor, for example, we had very poor diagnostic tools to alert the need for ASAP therapy, but these sensors can now alert providers when View Details
Keywords: April White
- 18 Nov 2014
- First Look
First Look: November 18
the continuing battle affect management, talent, and the company's financial performance? Purchase this case: https://hbr.org/product/Turkcell/an/715009-PDF-ENG Harvard Business School Case 615-024 Pfizer's Centers for Therapeutic... View Details
Keywords: Sean Silverthorne
- 25 Jul 2005
- Research & Ideas
An Organization Your Customers Understand
segmentation focuses on customer demographics: Will products be designed to appeal to wealthy, middle-market, or low-income customers? For the pharmaceutical business, segmentation is by therapeutic class: Will the firm focus on research... View Details
Keywords: by Robert Simons
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
heartburn, advertising may do more harm than good. Silk: Keep in mind that the use of DTCA by pharmaceutical companies is quite selective in that it tends to be concentrated in a relatively small number of therapeutic classes. The... View Details
Keywords: by Manda Salls
- 13 Jun 2005
- Research & Ideas
From Turf Wars to Learning Curves: How Hospitals Adopt New Technology
substitutable and the physician groups associated with each moved into closer competition with each other. Where turf wars do seem to have more of an impact is in how aggressively a hospital supports its initial investment in a given View Details
- 24 Sep 2020
- News
The Race for a Vaccine
Pisano says. But vaccines don’t really fit the same business model as high-volume therapeutic drugs; they have an even higher bar for safety and effectiveness, because unlike most other drugs they are administered to healthy populations.... View Details
- 11 May 2010
- First Look
First Look: May 11
narrowing horizontal breadth from over a dozen therapeutic classes to just three. In 2005, Levin hired Deborah Dunsire from Novartis as CEO to lead Millennium's continuing transformation. Students are asked to put themselves in the shoes... View Details
Keywords: Martha Lagace
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how... View Details
Keywords: Sean Silverthorne
- 01 Sep 2015
- First Look
First Look -- September 1, 2015
(TDABC) is an innovative costing tool in healthcare that can be used to directly compare the true cost of competing technologies over the full care cycle. Rather than only comparing therapeutic effectiveness over a limited number of... View Details
Keywords: Sean Silverthorne
- 17 Jun 2020
- News
Toronto Copes with COVID-19 Via Webinars; Alumni Respond to Pandemic in Philippines
Alumni Relations Boris Tsimerinov (PLDA16, 2017), the discussion focused on differences between the state of the COVID-19 crisis in Canada, the US, and the rest of the world. The webinar touched upon most recent clinical and therapeutic... View Details
Keywords: Margie Kelley
- 31 Oct 2017
- First Look
New Research and Ideas, October 31, 2017
Potential of Patient-Reported Outcomes By: Rotenstein, Lisa, Robert S. Huckman, and Neil Wagle Abstract—No abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=53372 forthcoming Clinical Pharmacology & View Details
Keywords: by Sean Silverthorne
- 26 Nov 2013
- First Look
First Look: November 26
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds Abstract—Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to... View Details
Keywords: Sean Silverthorne
- 09 Feb 2016
- First Look
February 9, 2016
a proxy contest and a special shareholder meeting to vote on replacing Allergan's directors with a slate more favorable to the Valeant merger. The proposed Salix acquisition would give Allergan a new therapeutic market but would also make... View Details
Keywords: Sean Silverthorne
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
significant published and implemented work in AI/algorithmic work already exists, we wanted to direct our interests to a therapeutic problem. The highly technical, image-related work of radiation oncology planning was highly suitable for... View Details
- 01 Jun 2000
- News
The Business of Biotech
information has a therapeutic use, we have to make a substantial investment - $350 to $500 million - in doing the clinical trial work. From a business standpoint, we need to protect our investment." "High, upstream knowledge should not be... View Details
Keywords: Julia Hanna
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already approved original... View Details
Keywords: Sean Silverthorne
- 23 Mar 2021
- Book
Succeeding in the New Work-from-Anywhere World
than fifty years, self-disclosure has been widely studied across a variety of interpersonal contexts, including friendships, romances, and therapeutic relations. The way to enhance trust between people is for all parties to self-disclose,... View Details
Keywords: by Michael Blanding
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
"But in order to determine that genetic information has a therapeutic use, we have to make a substantial investment—$350 to $500 million—in doing the clinical trial work. From a business standpoint, we need to protect our... View Details
- 08 Jun 2010
- First Look
First Look: June 8
uncertainty of commercial partners' interest in the therapeutic approach, and the constrained donor-based fundraising environment. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/610074-PDF-ENG Data.gov Karim R. Lakhani, Robert... View Details
Keywords: Martha Lagace
- 14 May 2020
- Research & Ideas
What Leaders Can Do to Fight the COVID Fog
well (and no one is there to watch you). Exercise is also an area where individuals have a great deal of control, which makes it a therapeutic activity in times of uncertainty. Short-term bursts of strenuous activity are not only... View Details
Keywords: by Boris Groysberg and Robin Abrahams